Literature DB >> 7989591

Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.

D E Kelley1, J A Simoneau.   

Abstract

This study was undertaken to assess utilization of FFA by skeletal muscle in patients with non-insulin-dependent diabetes mellitus (NIDDM). 11 NIDDM and 9 nondiabetic subjects were studied using leg balance methods to measure the fractional extraction of [3H]oleate. Limb indirect calorimetry was used to estimate RQ. Percutaneous muscle biopsy samples of vastus lateralis were analyzed for muscle fiber type distribution, capillary density, and metabolic potential as reflected by measurements of the activity of seven muscle enzyme markers of glycolytic and aerobic-oxidative pathways. During postabsorptive conditions, fractional extraction of oleate across the leg was lower in NIDDM subjects (0.31 +/- 0.08 vs. 0.43 +/- 0.10, P < 0.01), and there was reduced oleate uptake across the leg (66 +/- 8 vs. 82 +/- 13 nmol/min, P < 0.01). Postabsorptive leg RQ was increased in NIDDM (0.85 +/- 0.03 vs. 0.77 +/- 0.02, P < 0.01), and rates of lipid oxidation by skeletal muscle were lower while glucose oxidation was increased (P < 0.05). In subjects with NIDDM, proportions of type I, IIa, and IIb fibers were 37 +/- 2, 37 +/- 6, and 26 +/- 5%, respectively, which did not differ from nondiabetics; and capillary density, glycolytic, and aerobic-oxidative potentials were similar. During 6 h after ingestion of a mixed meal, arterial FFA remained greater in NIDDM subjects. Therefore, despite persistent reduced fractional extraction of oleate across the leg in NIDDM (0.34 +/- 0.04 vs. 0.38 +/- 0.03, P < 0.05), rates of oleate uptake across the leg were greater in NIDDM (54 +/- 7 vs. 45 +/- 8 nmol/min, P < 0.01). In summary, during postabsorptive conditions there is reduced utilization of FFA by muscle, while during postprandial conditions there is impaired suppression of FFA uptake across the leg in NIDDM. During both fasting and postprandial conditions, NIDDM subjects have reduced rates of lipid oxidation by muscle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989591      PMCID: PMC330064          DOI: 10.1172/JCI117600

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.

Authors:  N Nurjhan; A Consoli; J Gerich
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Intracellular defects in glucose metabolism in obese patients with NIDDM.

Authors:  D E Kelley; M Mokan; L J Mandarino
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

3.  Interpretation of oxygen and carbon dioxide exchange across tissue beds in vivo.

Authors:  K N Frayn; P Lund; M Walker
Journal:  Clin Sci (Lond)       Date:  1993-10       Impact factor: 6.124

4.  Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans.

Authors:  R C Bonadonna; L C Groop; K Zych; M Shank; R A DeFronzo
Journal:  Am J Physiol       Date:  1990-11

Review 5.  Role of liver in pathophysiology of NIDDM.

Authors:  A Consoli
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

6.  Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus.

Authors:  D E Kelley; L J Mandarino
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

Authors:  P Nuutila; V A Koivisto; J Knuuti; U Ruotsalainen; M Teräs; M Haaparanta; J Bergman; O Solin; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

8.  Electrical stimulation-induced changes in skeletal muscle enzymes of men and women.

Authors:  J M Gauthier; R Thériault; G Thériault; Y Gélinas; J A Simoneau
Journal:  Med Sci Sports Exerc       Date:  1992-11       Impact factor: 5.411

9.  Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus.

Authors:  D E Kelley; B S Slasky; J Janosky
Journal:  Am J Clin Nutr       Date:  1991-09       Impact factor: 7.045

10.  What if Minkowski had been ageusic? An alternative angle on diabetes.

Authors:  J D McGarry
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

View more
  135 in total

Review 1.  Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process.

Authors:  Madlyn Frisard; Eric Ravussin
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Conway Memorial Lecture 2002. The dyslipidaemia of diabetes: lessons in the pathogenesis of atherosclerosis.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Oct-Dec       Impact factor: 1.568

Review 3.  Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.

Authors:  Nicholas D Oakes; Bengt Ljung; Germán Camejo
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 4.  Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance.

Authors:  David E Kelley
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 5.  Gene expression in the pathophysiology of type 2 diabetes mellitus.

Authors:  Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

6.  Differences emerge in visceral adipose tissue accumulation after selection for innate cardiovascular fitness.

Authors:  D W Brock; B A Irving; B Gower; G R Hunter
Journal:  Int J Obes (Lond)       Date:  2010-07-20       Impact factor: 5.095

Review 7.  Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.

Authors:  Amirhossein Sahebkar; Luis E Simental-Mendía; Claudio Pedone; Gianna Ferretti; Petr Nachtigal; Simona Bo; Giuseppe Derosa; Pamela Maffioli; Gerald F Watts
Journal:  Br J Clin Pharmacol       Date:  2016-02-02       Impact factor: 4.335

Review 8.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

9.  Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.

Authors:  C B Renard; B Askari; L A Suzuki; F Kramer; K E Bornfeldt
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

10.  Skeletal muscle utilization of free fatty acids in women with visceral obesity.

Authors:  S R Colberg; J A Simoneau; F L Thaete; D E Kelley
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.